ClinicalTrials.gov
public full text
Public Domain
A1c Discordance in Diabetes Patients
HbA1c is used as a gold standard to see whether patients have optimal glycemic control. Today, many physicians rely solely on HbA1c to change medication. However, there is a select group of patients that have low average glucose levels but high HbA1c levels. The investigators believe that these patients are fast glycators meaning that they incorporate sugar into their hemoglobin faster than normal. The investigators want to determine whether these patients are fast glycators.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Correlation Between Glycated Hemoglobin and Mean Plasma Glucose in Hemodialysis Patients#838166
- HbA1c Prediction Model in Patients With Type 2 Diabetes#854962
- ABO-GLYC in Type 2 Diabetes#842205
- A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)#979139
- Effects of Modulators of Gluconeogenesis, Glycogenolysis and Glucokinase Activity#1150407
Record · ID 855455
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive